253 related articles for article (PubMed ID: 8540042)
1. Magnesium deficiency after renal transplantation and cyclosporine treatment despite normal serum-magnesium detected by a modified magnesium-loading-test.
Rob PM; Bley N; Dick K; Rohwer J; Sack K
Transplant Proc; 1995 Dec; 27(6):3442-3. PubMed ID: 8540042
[No Abstract] [Full Text] [Related]
2. [Magnesium deficiency after kidney transplantation and cyclosporine therapy].
Rob PM
Fortschr Med; 1996 Apr; 114(10):125-6. PubMed ID: 8655118
[No Abstract] [Full Text] [Related]
3. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
Sabbagh F; El Tawil Z; Lecerf F; Hulin A; Maurois P; Dartevelle P; Bac P; German-Fattal M
Transplantation; 2008 Aug; 86(3):436-44. PubMed ID: 18698248
[TBL] [Abstract][Full Text] [Related]
4. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
Ahmadi F; Naseri R; Lessan-Pezeshki M
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
[TBL] [Abstract][Full Text] [Related]
5. Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study.
Rodrigues N; Santana A; Guerra J; Neves M; Nascimento C; Gonçalves J; da Costa AG
Transplant Proc; 2017 May; 49(4):799-802. PubMed ID: 28457398
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
Gracida C; Melchor JL; Miranda ME; Bartolano C
Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
[No Abstract] [Full Text] [Related]
7. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine.
Hilbrands LB; Hoitsma AG; Wetzels JF; Koene RA
Clin Nephrol; 1996 Apr; 45(4):230-5. PubMed ID: 8861797
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
Navaneethan SD; Sankarasubbaiyan S; Gross MD; Jeevanantham V; Monk RD
Transplant Proc; 2006 Jun; 38(5):1320-2. PubMed ID: 16797291
[TBL] [Abstract][Full Text] [Related]
9. [Non-immunologic factor: immunosuppressive drug-induced nephrotoxicity].
Nakatani T; Asai T
Hinyokika Kiyo; 2002 Nov; 48(11):699-705. PubMed ID: 12512145
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
Offermann G; Korn A
Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201
[No Abstract] [Full Text] [Related]
11. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
[No Abstract] [Full Text] [Related]
13. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.
Gracida C; Melchor JL
Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318
[No Abstract] [Full Text] [Related]
14. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A
Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674
[TBL] [Abstract][Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile.
Woodside KJ; Nichols SD; Hunter GC; Gugliuzza KK; Daller JA
Transplant Proc; 2005 May; 37(4):1877-9. PubMed ID: 15919491
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of sandimmun neoral in cadaveric renal transplantation.
Xue W; Chen Y; Xing J; Tian P
Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
[No Abstract] [Full Text] [Related]
17. Cyclosporine-associated facial paralysis in a child with renal transplant.
Ozkaya O; Kalman S; Bakkaloğlu S; Buyan N; Söylemezoğlu O
Pediatr Nephrol; 2002 Jul; 17(7):544-6. PubMed ID: 12172772
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
Buchholz B; Korn A
Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
[No Abstract] [Full Text] [Related]
19. [The oral magnesium loading test for detecting possible magnesium deficiency].
Vizinová H; Bártek J; Jirka Z; Steidl L
Cas Lek Cesk; 1993 Oct; 132(19):587-9. PubMed ID: 8242695
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
Barone G; Bunke CM; Choc MG; Hricik DE; Jin JH; Klein JB; Marsh CL; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
